Therefore, it is suggested that the restoration of MAP2 and cholinergic system of AD mouse brain by the transplantation of F3.ChAT human NSCs resulted in the increased neuroregeneration, in addition to the neuroprotective action of GFs/NFs [10,43,44]. This evidence concerns the gene MAP2 and Alzheimer disease.